IMPACT OF FIXED-DOSE 4F-PCC ON TIME TO ADMINISTRATION FOR ANTICOAGULATION REVERSAL IN THE ED

被引：0
作者：
DeFilippo, Nicholas [1 ]
Jones, Kerri [1 ]
Pournezhad, Sam [2 ]
Patka, John [1 ]
Chester, Katleen [2 ]
Morrison, Christopher [1 ]
机构：
[1] Grady Mem Hosp, Atlanta, GA USA
[2] Grady Hlth Syst, Emeryville, CA USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
10.1097/01.ccm.0000909756.64133.fc
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1007
引用
收藏
页码：497 / 497
页数：1
相关论文
共 50 条
[31]   FIXED-DOSE FOUR-FACTOR PCC FOR THE REVERSAL OF FACTOR XA INHIBITOR-ASSOCIATED BLEEDING [J].
Cycz, Clare ;
Philips, Eli ;
Elsamadisi, Pansy .
CRITICAL CARE MEDICINE, 2023, 51 (01) :155-155
[32]   Impact of Fixed-Dose Prothrombin Complex Concentrate (Human) versus Weight-Based Dosing in the Emergent Anticoagulation Reversal of Warfarin [J].
Vi Pham Nhat Nguyen ;
Heermans, Kathryn .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025, 82 :S1066-S1066
[33]   A Low-Dose 4F-PCC Protocol for DOAC-Associated Intracranial Hemorrhage [J].
Berger, Karen ;
Santibanez, Melissa ;
Lin, Lina ;
Lesch, Christine A. .
JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (11) :1203-1208
[34]   Impact of 4-Factor Prothrombin Complex Concentrate (4F-PCC) Protocol in Patients Not on Anticoagulants [J].
Luo, Amy ;
Abid, Sam ;
Snyder, Julie .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025, 82 :S1022-S1022
[35]   Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors [J].
Jing Tao ;
Elena N. Bukanova ;
Shamsuddin Akhtar .
Journal of Intensive Care, 6
[36]   EVALUATION OF 4F-PCC IN OBESE VERSUS NON-OBESE PATIENTS FOR FACTOR XA INHIBITOR REVERSAL [J].
Ciborowski, Megan ;
Nakajima, Steven ;
Sparks, Eric ;
McKinney, James, III .
CRITICAL CARE MEDICINE, 2020, 48
[37]   Evaluation of Four Factor Prothrombin Concentration Complex (4F-PCC) Usage in the Emergency Department for Anticoagulant Reversal [J].
Huizenga, Kristyn C. ;
Daberko, Jennifer ;
Palausky, Melissa .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025, 82 :S826-S827
[38]   Pharmacometric modeling to explore 4F-PCC dosing strategies for VKA reversal in patients with INR below 2 [J].
Sarode, Ravi ;
Fukutake, Katsuyuki ;
Yasaka, Masahiro ;
Tortorici, Michael A. ;
Mangione, Antoinette ;
Pfister, Marc ;
Cuker, Adam .
BLOOD ADVANCES, 2020, 4 (17) :4208-4216
[39]   EFFICACY AND SAFETY OF 4F-PCC VS. FFP FOR WARFARIN REVERSAL IN EMERGENT SURGERY/INVASIVE PROCEDURE [J].
Mazur, Hannah ;
Young, Sarah ;
McGraw, Molly ;
Montepara, Courtney .
CRITICAL CARE MEDICINE, 2019, 47
[40]   4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal [J].
Lang, Eddy .
ANNALS OF INTERNAL MEDICINE, 2014, 160 (08)
12345